Progress of mesenchymal stem cell therapy for neural and retinal diseases
- PMID: 24772238
- PMCID: PMC3999769
- DOI: 10.4252/wjsc.v6.i2.111
Progress of mesenchymal stem cell therapy for neural and retinal diseases
Abstract
Complex circuitry and limited regenerative power make central nervous system (CNS) disorders the most challenging and difficult for functional repair. With elusive disease mechanisms, traditional surgical and medical interventions merely slow down the progression of the neurodegenerative diseases. However, the number of neurons still diminishes in many patients. Recently, stem cell therapy has been proposed as a viable option. Mesenchymal stem cells (MSCs), a widely-studied human adult stem cell population, have been discovered for more than 20 years. MSCs have been found all over the body and can be conveniently obtained from different accessible tissues: bone marrow, blood, and adipose and dental tissue. MSCs have high proliferative and differentiation abilities, providing an inexhaustible source of neurons and glia for cell replacement therapy. Moreover, MSCs also show neuroprotective effects without any genetic modification or reprogramming. In addition, the extraordinary immunomodulatory properties of MSCs enable autologous and heterologous transplantation. These qualities heighten the clinical applicability of MSCs when dealing with the pathologies of CNS disorders. Here, we summarize the latest progress of MSC experimental research as well as human clinical trials for neural and retinal diseases. This review article will focus on multiple sclerosis, spinal cord injury, autism, glaucoma, retinitis pigmentosa and age-related macular degeneration.
Keywords: Central nervous system; Clinical trial; Mesenchymal stem cells; Retina; Stem cell therapy.
Similar articles
-
The role of mesenchymal stromal cells in spinal cord injury, regenerative medicine and possible clinical applications.Biochimie. 2013 Dec;95(12):2257-70. doi: 10.1016/j.biochi.2013.08.004. Epub 2013 Aug 27. Biochimie. 2013. PMID: 23994163 Review.
-
Mesenchymal Stem Cell-Based Therapy for Retinal Degenerative Diseases: Experimental Models and Clinical Trials.Cells. 2021 Mar 7;10(3):588. doi: 10.3390/cells10030588. Cells. 2021. PMID: 33799995 Free PMC article. Review.
-
A Promising Tool in Retina Regeneration: Current Perspectives and Challenges When Using Mesenchymal Progenitor Stem Cells in Veterinary and Human Ophthalmological Applications.Stem Cell Rev Rep. 2017 Oct;13(5):598-602. doi: 10.1007/s12015-017-9750-4. Stem Cell Rev Rep. 2017. PMID: 28643176 Free PMC article. Review.
-
Cytokine interplay among the diseased retina, inflammatory cells and mesenchymal stem cells - a clue to stem cell-based therapy.World J Stem Cells. 2019 Nov 26;11(11):957-967. doi: 10.4252/wjsc.v11.i11.957. World J Stem Cells. 2019. PMID: 31768222 Free PMC article. Review.
-
Human Mesenchymal Stem Cell Secretome Exhibits a Neuroprotective Effect over In Vitro Retinal Photoreceptor Degeneration.Mol Ther Methods Clin Dev. 2020 May 13;17:1155-1166. doi: 10.1016/j.omtm.2020.05.003. eCollection 2020 Jun 12. Mol Ther Methods Clin Dev. 2020. PMID: 32514411 Free PMC article.
Cited by
-
Combined Transplantation With Human Mesenchymal Stem Cells Improves Retinal Rescue Effect of Human Fetal RPE Cells in Retinal Degeneration Mouse Model.Invest Ophthalmol Vis Sci. 2020 Jul 1;61(8):9. doi: 10.1167/iovs.61.8.9. Invest Ophthalmol Vis Sci. 2020. PMID: 32639552 Free PMC article.
-
miRNA-based therapeutic potential of stem cell-derived extracellular vesicles: a safe cell-free treatment to ameliorate radiation-induced brain injury.Int J Radiat Biol. 2019 Apr;95(4):427-435. doi: 10.1080/09553002.2018.1522012. Epub 2018 Sep 25. Int J Radiat Biol. 2019. PMID: 30252569 Free PMC article. Review.
-
The ERK signaling pathway is involved in cardiotrophin-1-induced neural differentiation of human umbilical cord blood mesenchymal stem cells in vitro.Cytotechnology. 2019 Oct;71(5):977-988. doi: 10.1007/s10616-019-00339-w. Epub 2019 Sep 5. Cytotechnology. 2019. PMID: 31489528 Free PMC article.
-
Mesenchymal stem cells attenuate hydrogen peroxide-induced oxidative stress and enhance neuroprotective effects in retinal ganglion cells.In Vitro Cell Dev Biol Anim. 2017 Apr;53(4):328-335. doi: 10.1007/s11626-016-0115-0. Epub 2016 Nov 18. In Vitro Cell Dev Biol Anim. 2017. PMID: 27864663
-
Current perspectives in mesenchymal stem cell therapies for osteoarthritis.Stem Cells Int. 2014;2014:194318. doi: 10.1155/2014/194318. Epub 2014 Dec 8. Stem Cells Int. 2014. PMID: 25548573 Free PMC article. Review.
References
-
- Wagers AJ, Weissman IL. Plasticity of adult stem cells. Cell. 2004;116:639–648. - PubMed
-
- Horwitz EM, Le Blanc K, Dominici M, Mueller I, Slaper-Cortenbach I, Marini FC, Deans RJ, Krause DS, Keating A. Clarification of the nomenclature for MSC: The International Society for Cellular Therapy position statement. Cytotherapy. 2005;7:393–395. - PubMed
-
- Ding DC, Shyu WC, Lin SZ. Mesenchymal stem cells. Cell Transplant. 2011;20:5–14. - PubMed
-
- Dominici M, Le Blanc K, Mueller I, Slaper-Cortenbach I, Marini F, Krause D, Deans R, Keating A, Prockop Dj, Horwitz E. Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. Cytotherapy. 2006;8:315–317. - PubMed
-
- Tárnok A, Ulrich H, Bocsi J. Phenotypes of stem cells from diverse origin. Cytometry A. 2010;77:6–10. - PubMed
Publication types
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources